FoxM1 might be in turn upregulated by high-mobility group AT-hook 2 (HMGA2), a protein that was demonstrated to be highly expressed in Grade II-IV gliomas, supporting GBM cell invasive behavior [112]. This evidence concerns the gene FOXM1 and central nervous system cancer.